You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Normal allogeneic donors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Haplo-identical Transplantation, Transplantation Trial in Paris (Evaluate the evolution of the psychic state of the donors

Not yet recruiting
  • Haplo-identical Transplantation
  • Transplantation
  • Evaluate the evolution of the psychic state of the donors (ascendants and descendants), by means of questionnaires, within the framework of haplo-identical allograft.
  • Paris, France
    Service D'hématologie Clinique et thérapie cellulaire - Hôpital
Oct 17, 2023

Allogenic Granulocyte Donation Trial run by the National Institutes of Health Clinical Center (CC) (Filgrastim, Dexamethasone)

Recruiting
  • Allogeneic Granulocyte Donation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 7, 2023

Selection of Allogeneic Hematopoietic Cell Donors Based on KIR

Active, not recruiting
  • Leukemia
  • KIR genotyping
  • HLA genotyping
  • Tampa, Florida
  • +9 more
Nov 29, 2022

Multiple Myeloma Trial in Hamburg (allogeneic HSCT)

Completed
  • Multiple Myeloma
  • allogeneic HSCT
  • Hamburg, Germany
    University Medical Center Hamburg-Eppendorf
Sep 1, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Duarte, California
  • +1 more
Sep 22, 2023

HPV 16+ Recurrent or Metastatic Cancer Trial (CD8 reduced peripheral blood cells taken from related donors vaccinated against

Not yet recruiting
  • HPV 16+ Recurrent or Metastatic Cancer
  • CD8 reduced peripheral blood cells taken from related donors vaccinated against HPV16
  • Non-myeloablative allogeneic bone marrow transplant from related donors vaccinated against HPV16
  • (no location specified)
Jun 27, 2022

Myeloid Malignancies, Lymphoid Malignancies Trial in Durham (NK Cell enriched-DLI only, NK-DLI + DUK-CPG-001)

Recruiting
  • Myeloid Malignancies
  • Lymphoid Malignancies
  • NK Cell enriched-DLI only
  • NK-DLI + DUK-CPG-001
  • Durham, North Carolina
    Duke University Health System
Mar 8, 2022

Healthy Trial in United States (Filgrastim)

Recruiting
  • Healthy
  • Duarte, California
  • +19 more
Mar 7, 2022

Multi-Drug Resistant Organism Trial in Decatur (Allogeneic Microbiota in Glycerol (10%) (AMG))

Not yet recruiting
  • Multi-Drug Resistant Organism
  • Allogeneic Microbiota in Glycerol (10%) (AMG)
  • Decatur, Georgia
    Emory Long-Term Acute Care
Mar 20, 2023

Hematologic Diseases Trial in Palo Alto (Allogeneic Stem Cell Transplant, CliniMACS TCR a/ß Reagent Kit and CliniMACS CD19)

Recruiting
  • Hematologic Diseases
  • Allogeneic Stem Cell Transplant
  • CliniMACS TCR α/β Reagent Kit and CliniMACS CD19
  • Palo Alto, California
    Lucile Packard Children's Hospital
Feb 2, 2022

Ischemia Reperfusion Injury Trial in Jacksonville (Allogeneic adipose derived mesenchymal stem cells)

Recruiting
  • Ischemia Reperfusion Injury
  • Allogeneic adipose derived mesenchymal stem cells
  • Jacksonville, Florida
    Mayo Clinic in Florida
Oct 7, 2021

Hematological Malignancies Trial in Belgium, Netherlands (Conditioning regimen: TBI + Fludarabine, Conditioning regimen:TLI (8

Completed
Has Results
  • Hematological Malignancies
  • Conditioning regimen: TBI + Fludarabine
  • Conditioning regimen:TLI (8 Gy) + ATG
  • Leuven, Flamish Brabant, Belgium
  • +10 more
Nov 16, 2021

Hematologic Malignancies Trial in Baltimore (drug, radiation, procedure)

Recruiting
  • Hematologic Malignancies
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 14, 2022

COVID-19 Infection Trial in Taichung (Allogeneic umbilical cord mesenchymal stem cells, Controlled normal saline)

Active, not recruiting
  • COVID-19 Infection
  • Allogeneic umbilical cord mesenchymal stem cells
  • Controlled normal saline
  • Taichung, Non-US, Taiwan
    China Medical University Hospital
Aug 11, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New Hyde Park (radiation, drug,

Completed
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Radiation
  • +3 more
  • New Hyde Park, New York
    Cohen Children's Medical Center
Apr 6, 2022

Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem

Active, not recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies
  • Recipients
  • Donors
  • Paris, France
    Hopital Necker
Nov 19, 2021

Hematologic Diseases Trial in Palo Alto (biological, device, drug)

Recruiting
  • Hematologic Diseases
  • Allogeneic Stem Cell Transplant
  • +2 more
  • Palo Alto, California
    Lucile Packard Children's Hospital
Mar 25, 2022

Iron Deficiency Trial in New York (Iron-dextran, Saline, Blood Donation)

Active, not recruiting
  • Iron Deficiency
  • New York, New York
    Columbia University Medical Center
Feb 14, 2022

Lymphoma Trial in Madison (drug, radiation, biological, procedure)

Completed
Has Results
  • Lymphoma
  • Fludarabine Phosphate
  • +9 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Dec 7, 2021

Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia Trial in United States (MGTA-145,

Terminated
  • Related Donors Donating PBSC to a Family Member
  • +4 more
  • MGTA-145
  • Plerixafor
  • Duarte, California
  • +7 more
Apr 13, 2022

Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial in New York (radiation, drug,

Active, not recruiting
  • Acute Lymphoid Leukemia (ALL)
  • +5 more
  • Hyperfractionated total body irradiation
  • +9 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Hematological Malignancies Trial in Philadelphia (radiation, drug, genetic)

Recruiting
  • Hematological Malignancies
  • Total Body Irradiation
  • +6 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 4, 2022

Post COVID-19 Syndrome Trial in Sugar Land (HB-adMSCs (allogeneic), Placebo)

Recruiting
  • Post COVID-19 Syndrome
  • HB-adMSCs (allogeneic)
  • Placebo
  • Sugar Land, Texas
    Hope Biosciences Stem Cell Research Foundation
Feb 2, 2022

Idiopathic Parkinson Disease Trial in Houston ([21CFR640.30] Plasma from 18 - 25 year old volunteer donors, Saline)

Completed
  • Idiopathic Parkinson Disease
  • [21CFR640.30] Plasma from 18 - 25 year old volunteer donors
  • Saline
  • Houston, Texas
    The Neurology Center
Dec 14, 2021

Perianal Fistula, Crohn's Disease Trial (ExoFlo, Local injection of normal saline)

Not yet recruiting
  • Perianal Fistula
  • Crohn's Disease
  • ExoFlo
  • Local injection of normal saline
  • (no location specified)
Apr 19, 2023